Selected Abstracts from the October Issue of the Journal of Vascular Surgery  by unknown
Eur J Vasc Endovasc Surg 34, 489e491 (2007)
doi:10.1016/S1078-5884(07)00522-9, available online at http://www.sciencedirect.com onSelected Abstracts from the October Issue of the Journal of Vascular Surgery*Vascular surgery training and certification: An international perspective
J.L. Cronenwett and C.D. Liapis
Objective. Vascular surgery (VS) practice has expanded to incorporate inter-
ventional procedures, and this has stimulated changes in training. The pur-
pose of this study was to review current VS training and certification in
different countries.
Methods. A survey was completed by vascular surgeons involved with na-
tional certification in 34 countries. Results are expressed as the mean  SD,
with comparisons by c2 and t tests.
Results. VS is currently an independent specialty in 15 surveyed countries,
is a subspecialty of general surgery in 10 countries, and is not recognized as
a specialty in 9 countries. There has been a clear time trend toward indepen-
dent certification. In countries with independent VS certification, the length
of VS training is 3.7  0.9 years plus 2.3  0.7 years of associated core gen-
eral surgery (GS), for a total training length of 5.9  1.0 years. In countries
with VS subspecialty certification, the length of VS training is 2.4  0.5 years
after 5.0  1.1 years of GS, for a total training length of 7.4  1.2 years (each
P < .01 vs independent certification). The minimum required volume of
major open VS operations during training is 151  78 in countries with
independent VS certification vs 113  53 in countries with subspecialty cer-
tification. Endovascular requirements for training are established in 71% of
countries with independent certification vs 37% of countries with subspe-
cialty certification (P < .03). Countries with independent VS certification
produce 5.4  2.8 VS trainees per year per million population 65 years of
age or older, vs 3.0  1.8 in countries with subspecialty certification
(P < .02).
Conclusions. Considerable variation exists in VS training in different coun-
tries. There is an international movement toward independent VS certifica-
tion, with longer VS specific training but shorter overall residency
duration. Counties with independent VS certification produce more trainees
per year to serve their elderly population.
Abdominal aortic aneurysm in women: Prevalence, risk factors, and
implications for screening
B.G. DeRubertis, S.M. Trocciola, E.J. Ryer, F.M. Pieracci, J.F. McKinsey,
P.L. Faries and K.C. Kent
Objective. Accurate data regarding the prevalence and associated risk factors
for aneurysmal disease is essential when determining the appropriateness of
screening for abdominal aortic aneurysms (AAA). Although women are
poorly represented in most large studies of AAA prevalence, the US Preven-
tative Services Task Force recently recommended against primary screening
for AAA in women. The purpose of this analysis was to define the prevalence
and risk factors associated with the development of AAA in women.
Methods. A free duplex ultrasound screening was offered to men and women
with cardiovascular risk factors or a family history of AAA. Patients were re-
cruited through advertising at local screening centers and screenings were
performed between 2004 and 2006. Demographic information and cardiovas-
cular and aneurysmal disease risk factors were obtained for each patient
through a questionnaire. A total of 17,540 subjects were screened for AAA,
including 10,012 women (mean age 69.6 years) and 7528 men (mean age
70.0 years). Univariate and multivariable logistic regression analysis was per-
formed on the subset of women that were screened to determine risk factors
for and prevalence of AAA.
Results. Seventy-four aneurysms were detected in women (including four
aneurysms >5 cm diameter and 70 aneurysms 3 to 5 cm diameter) while
291 were detected in men, resulting in prevalence rates of 0.7% and 3.9%, re-
spectively. Increasing age (odds ratio [OR]= 4.57, 95% confidence interval [CI]
1.98 to 10.54, P < .0001), history of tobacco use (OR ¼ 3.29, 95% CI 1.86 to 5.80,
P < .0001), and cardiovascular disease (OR= 3.57, 95% CI 2.19 to 5.84, P <
.0001) were independently associated with AAA in women on univariate
and multivariable analysis. Women with multiple atherosclerotic risk factors
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AAA as high as 6.4%.
Conclusion. Although the medical literature suggests a low prevalence rate of
AAA in women in the general population, specific risk factors are associated
with the development of AAA, and subgroups of women can be identified
that are at a substantially increased risk of aneurysmal disease. In particular,
elevated rates of AAAwere found among women of advanced age (65 years)
with a history of smoking or heart disease. These data support the notion that
women with such risk factors should be considered for AAA screening.
Endovascular repair of para-anastomotic aortic aneurysms
U. Sachdev, D.T. Baril, N.J. Morrissey, D. Silverberg, T.S. Jacobs,
A. Carroccio, S. Ellozy and M.L. Marin
Background. Para-anastomotic aneurysms involving the aorta and iliac
arteries can occur years after aortic surgery and are at risk for rupture and
erosion into surrounding structures. We report on our continued experience
with patients who have been treated for these lesions with endovascular
management as an alternative to traditional open repair.
Methods. Patients who underwent endovascular repair of para-anastomotic
aneurysms involving the distal aortic arch, descending thoracic aorta,
abdominal aorta, or iliac arteries were prospectively followed up in a data-
base. Patient comorbidities, initial aortic pathology, initial graft configuration,
aneurysm characteristics, evidence of infection, type and configuration of
endograft used, and follow-up were analyzed.
Results. From 1997 to 2006, 53 patients with 65 para-anastomotic aneurysms
were treated with endovascular stent grafts. Patients who were originally
treated for aortoiliac occlusive disease presented significantly later than those
treated for aneurysmal disease (15.8 vs 8.9 years, P < .01). The initial technical
success rate was 98%. Endoleaks were identified in six patients (11%) 1
month of surgery, and three required reintervention, including open conver-
sions. Endoleak complications were significantly associated with patients
who had symptomatic para-anastomotic aneurysms (P ¼ .01). Perioperative
mortality after endovascular repair was 3.8%. Overall mortality within
a mean follow-up of 18 months was 49% and was significantly associated
with older age at the time of endovascular treatment (P ¼ .03).
Conclusion. Endovascular repair of para-anastomotic aneurysms involving
the aorta and iliac arteries is technically feasible and is associated with
a low perioperative morbidity and mortality. Close follow-up is required to
identify endoleaks. Long-term survival is limited in older patients. We recom-
mend endovascular stent graft repair for para-anastomotic aneurysms in an-
atomically suitable patients.
Clinical factors associated with long-term mortality following vascular
surgery: Outcomes from The Coronary Artery Revascularization
Prophylaxis (CARP) Trial
E.O. McFalls, H.B. Ward, T.E. Moritz, F. Littooy, S. Santilli, J. Rapp, G. Larsen
and D.J. Reda
Background. Preoperative cardiac risks and clinical indications for vascular
surgery are both important determinants of outcome following a vascular op-
eration. Using the nonrandomized cohort from the Coronary Artery Revascu-
larization Prophylaxis (CARP) Trial, we analyzed the predictors of outcome
based on the presenting vascular problem and prevalence of comorbid con-
ditions and cardiac risks.
Methods and Results. Between March 1, 1999 and February 28, 2003, 4414 pa-
tients were ineligible for randomization in the CARP Trial and their survival
was retrieved through the BIRLS system (the Department of Veterans Affairs
Beneficiary Identification and Records Locator Subsystem). Surgical indica-
tions were either an abdominal aortic aneurysm (N ¼ 1598) or lower extrem-
ity ischemia for claudication (N ¼ 1116), rest pain (N ¼ 670), or tissue loss
(N ¼ 1030). Patients were screened for major cardiac risks that included a
history of angina, congestive heart failure, myocardial infarction, ventricularSeptember 2007  489/491
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490 Abstractsarrhythmias, pathological q-waves, and diabetes. The absence of multiple
cardiac risks, as the sole reason for exclusion from randomization, occurred
in 2314 (52.4%) screened patients and their probability of survival at 2.5-
year post-surgery was 0.88. This was better than the survival of the remaining
excluded patients (N ¼ 2100), which was 0.75 (P < .0001) and the randomized
cohort (N ¼ 462), which was 0.80 (P < .0001). By Cox regression analysis, ur-
gent surgery, congestive heart failure, ventricular arrhythmias and creatinine
>3.5 mg/dL were significantly associated with long-term postoperative
mortality.
Conclusions. Patients without multiple cardiac risks or comorbid conditions
have a good outcome following elective vascular surgery. Urgent surgery, cre-
atinine >3.5 mg/dL, congestive heart failure, and ventricular arrhythmias are
identifiers of a poor long-term outcome and may justify aggressive strategies
for risk-stratification in the postoperative period.
Prospective decision analysis for peripheral vascular disease predicts
future quality of life
T.E. Brothers, J.G. Robison and B.M. Elliott
Objective. Decision making for peripheral vascular disease can be quite
complex as a result of pre-existing compromise of patient functional status,
anatomic considerations, uncertainty of favorable outcome, medical comor-
bidities, and limitations in life expectancy. The ability of prospective deci-
sion-analysis models to predict individual quality of life in patients with
lower extremity arterial occlusive disease was tested.
Methods. This was a prospective cohort study. The settings were university
and Veterans Administration vascular surgery practices. All 214 patients re-
ferred with symptomatic lower extremity arterial disease of any severity
over a 2-year period were screened, and 206 were enrolled. A Markov model
was compared with standard clinical decision-making. Utility assessment
and generalized (Short Form-36; SF-36) and disease-specific (Walking Impair-
ment Questionnaire; WIQ) quality of life were derived before treatment. Es-
timates of treatment outcome probabilities and intended and actual treatment
plans were provided by attending vascular surgeons. The main outcome
measures were generalized (SF-36) and disease-specific (WIQ) variables at
study entry and at 4 and 12 months.
Results. Primary intervention consisted of amputation for 9, bypass for 42,
angioplasty for 8, and medical treatment for 147 patients. Considering all
patients, no improvement in mean overall patient quality of life measured
by the SF-36 Physical Component Score (27  8 vs 28  8; P ¼ .87) or WIQ
(39  22 vs 39  23; P ¼ .13) was noted 12 months after counseling and treat-
ment by the vascular surgeons. Individually considered SF-36 categories
were improved only for Bodily Pain (40  23 vs 49  25; P ¼ .03), with the
most significant improvement observed among patients with the most severe
pain (68  25 vs 37  23; P ¼ .02) and among those undergoing bypass (60 
29 vs 31  22; P ¼ .02). It is noteworthy that when the treatment chosen was
incongruent with the Markov model, patients were more likely to report
a poorer quality of life at 1 year (Physical Component Score, 25  8 vs 29
 8; P < .001). The quality of life predicted at baseline by the Markov model
correlated positively with the Physical Component Score (r ¼ 0.23), Bodily
Pain (r ¼ 0.33), and Fatigue (r ¼ 0.44) and negatively with WIQ (r ¼ 0.08)
observed 1 year later.
Conclusions. Prospective application of an individualized decision Markov
model in patients with vascular disease was predictive of patient quality of
life at 1 year. The patient’s outcome was worse when the treatment received
did not follow the model’s recommendation. This decision analysis model
may be useful to identify patients at risk for poor outcomes with standard
clinical decision making.
Lesion severity and treatment complexity predict outcome following
percutaneous infra-inguinal intervention for lower extremity ischemia
B.G. DeRubertis, M. Pierce, R.A. Chaer, S.J. Rhee, R. Benjeloun, E.J. Ryer,
C. Kent and P.L. Faries
Objectives. Percutaneous revascularization has become increasingly utilized
for the treatment of lower extremity ischemia. Patients with limb-threat have
been shown to be at increased risk of failure, although the reasons for thisEur J Vasc Endovasc Surg Vol 34, October 2007remain unclear. This study analyzed factors predictive of percutaneous treat-
ment failure, focusing specifically on lesion characteristics and treatment
complexity.
Methods. We retrospectively reviewed percutaneous infra-inguinal interven-
tions performed for peripheral occlusive disease between 2002 and 2005
using a prospectively maintained database. Lesion characteristics were as-
sessed by angiography, and lesionswere graded according to the TransAtlantic
InterSociety Consensus (TASC) criteria. Patency was expressed by Kaplan-
Meiermethod andcomparedby log-rank analysis.MultivariateCox-regression
analysis was used to assess significant factors on univariate analysis. Mean
follow-up was 11.8 months.
Results. A total of 324 interventions for claudication (55.8%), rest pain
(18.4%), or tissue loss (25.8%) were analyzed, including 284 primary interven-
tions and 40 re-interventions in 258 patients (mean age 72.1  10 years, 51.0%
male). TASC lesion grades included: A (4.9%), B (29.3%), C (37.7%), and D
(28.1%). Isolated single-level interventions (femoral, popliteal, or tibial)
were performed in 38.9%, while two-level interventions were performed in
46.2% and three-level interventions in 14.9%. Overall primary patency (
SD) at 6, 12, and 18 months was 87  2%, 66  2% and 59  4%, respectively.
Secondary patency at 6, 12, and 18 months was 89  2%, 76  3%, and 69 
5%. One-year limb salvage rate (limb-threat patients) was 85  3%. Limb-
threatening ischemia as the indication for intervention was the strongest pre-
dictor of failure of both primary and secondary patency and was associated
with four indicators of lesion severity and treatment complexity, including in-
creasing TASC grade, multilevel intervention, tibial intervention, and re-
duced tibial outflow. One-year primary patency was inversely correlated
with TASC severity (TASC A-C: 67  6%, D: 61  4%; P < .05), multilevel in-
tervention (76  5% and 49  9% for single vs multilevel, P ¼ .002), distal in-
terventions (74  5% and 57  7% for femoral vs tibial, P < .05), and
decreased tibial runoff (83  6% and 52  6% for three- vs < three-vessels,
P < .02). No differences in secondary patency or limb-salvage rates existed
for these lesion- and treatment-related variables. Multilevel intervention
and tibial intervention remained significant independent predictors of pri-
mary patency on multivariate analysis.
Conclusions. Patients with limb-threatening ischemia are at increased risk of
initial failure compared with claudicants, likely as a result of the increased
prevalence of advanced lesion severity and treatment complexity, which pre-
dict decreased primary patency. However, this finding did not extend to sec-
ondary patency or limb-salvage in the overall patient population. Although
additional studies with longer follow-up are needed, these findings argue
that percutaneous intervention may still be considered as a primary treat-
ment modality with the understanding that these patients may have higher
re-intervention rates and may ultimately require salvage open surgical by-
pass for persistent failures of percutaneous therapy.
Factors associated with outcome after interventional treatment of
symptomatic iliac vein compression syndrome
B.S. Knipp, E. Ferguson, D.M. Williams, N.J. Dasika, W. Cwikiel, P.K. Henke
and T.W. Wakefield
Background. Iliac vein compression syndrome (IVCS) results from compres-
sion of the left iliac vein by the overlying right iliac artery against the pelvic
brim. In many cases, patients are symptomatic. In symptomatic cases, man-
agement consists of angioplasty and stenting. Although therapy is often ini-
tially successful, factors associated with long-term outcome have been poorly
defined. The purpose of this study was to identify factors associated with
stent patency.
Methods. The medical records of all patients who underwent iliac vein percuta-
neous transluminal angioplasty and stenting from January 1996 to December
2006 for symptomatic IVCS were reviewed retrospectively. There were 50
women and 8 men, with a mean age of 42 years (median, 39 years; range,
17e71 years). Primary, assisted primary, and secondary patency rates were
determined. Patient characteristics and clinical variables were evaluated by
univariate andmultivariate analysis to determine association with vein patency.
Results. Symptoms consisted of lower extremity swelling (81%) and lower
extremity pain (67%). Iliac vein obstruction was treated with pharmacologic
thrombolysis (31% of patients) and mechanical thrombus fragmentation (17%
of patients). The primary, assisted primary, and secondary patency rates of
angioplasty/stenting were 74.1%, 79.7%, and 85.8% at 1 year and 38.1%,
491Abstracts62.8%, and 73.8% at 5 years, respectively. Using a Cox proportional risk
model, male sex (hazard ratio, 6.5; P ¼ .001), recent trauma (hazard ratio,
5.3; P ¼ .001), and age younger than 40 years (hazard ratio, 3.8; P ¼ .015)
were associated with decreased primary patency. In the absence of any risk
factors, primary patency was 94.4% at 1 year and 63.0% at 5 years, decreasing
to 28.6% and 0% for two or more risk factors.
Conclusions. Patency rates for iliac vein percutaneous transluminal angio-
plasty and stenting in patients with IVCS can potentially be predicted on
the basis of a multivariate model. Assessing risk factors allows for patient
stratification and appropriate clinical decision making. Prospective validation
of these variables is necessary.
A randomized trial of the Tubulcus multilayer bandaging system in the
treatment of extensive venous ulcers
D.J. Milic, S.S. Zivic, D.C. Bogdanovic, Z.D. Perisic, Z.D. Milosevic,
R.J. Jankovic, A.M. Visnjic and B.M. Jovanovic
Background. Venous ulcers are a major health problem because of their high
prevalence and associated high cost of care. Compression therapy is the most
widely used treatment for this condition. The vast majority of published ar-
ticles on compression therapy present the results in the treatment of venous
ulcers usually up to 15 to 20 cm2. However, there are no published data in
English medical literature on the efficacy of compression therapy in the treat-
ment of extensive venous ulcers (ulcers >20 cm2 of more than 6 months’ du-
ration) with regard to healing rate, time to healing, and recurrence rate at 12
months after healing.Methods. A total of 138 patients with extensive venous ulceration (ulceration
surface, 20e210 cm2; duration, 7 months to 28 years) were randomized into 2
groups: (1) a treatment group (72 patients who were treated by using a mul-
tilayer bandaging system with the Tubulcus (a heelless open-toed elastic com-
pression device knitted in tubular form) and elastic bandages and (2)
a control group (66 patients treated with a multilayer bandaging system
with elastic bandages only). The patients were treated on an ambulatory ba-
sis; the primary end point of the study was complete ulcer healing at 500
days. The secondary end point was to assess the ulcer recurrence rate during
continuation of below-knee compression of different degrees of compression.
In the treatment group, patients were instructed to continue to wear the Tu-
bulcus (35 mm Hg), and patients in the control group were instructed to wear
compression stockings with compression of 20 to 25 mm Hg. The exclusion
criteria from the study were heart insufficiency with an ejection fraction
<35, an ankle-brachial pressure index less than 0.8, and pregnancy.
Results. The cumulative healing rate was 93% in the treatment group and
was 51% in the control group (P < .001). The median healing time in the treat-
ment group was 133 days (range, 28e464 days), and in the control group it
was 211 days (range, 61e438 days). The recurrence rate at 12 months in the
treatment group was 24% (16/67) and was 53% (18/34) in the control group
(P < .05). After additional compression treatment with the same treatment
protocol, all 16 recurrent ulcers in the treatment group healed. In the control
group, the healing rate of recurrent ulcers was 89% (16/18).
Conclusions. This study suggests that for extensive venous ulceration, multi-
layer compression therapy with the Tubulcus provides an extremely high
healing rate. Compression of more than 30 mm Hg results in decreased ulcer
recurrence. However, recurrence cannot be completely avoided.Eur J Vasc Endovasc Surg Vol 34, October 2007
